UnitedHealth Group Faces Scrutiny Amid Rising Revenue
UnitedHealth Group Inc., the world's seventh-largest company by revenue and largest healthcare corporation, has faced numerous investigations, lawsuits, and penalties for various issues, including SEC enforcement related to stock option backdating, Medicare overbilling, unfair claims practices, denials of mental health treatments, and anticompetitive conduct.
The company's revenue has been steadily increasing, averaging 20.62% year-over-year growth over the past three years, with a market capitalization of $460.3 billion as of December 20, 2024.
UnitedHealth Group pays high dividends, with a payout ratio of 52.29%, and has consistently paid dividends over the past five years.
The company's PE is at a high 30.66, indicating it may be overvalued, and institutional investors have been selling shares, decreasing holdings by 0.47% quarter-over-quarter.